
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
For many patients with multiple myeloma, how a regimen is dosed may matter more than how many agents are included, according to Ajai Chari, MD, of the University of California San Francisco. As the field explores novel triplet and quadruplet combinations, …